C4 Therapeutics Inc. (CCCC)
2.52
-0.19 (-7.01%)
At close: Mar 03, 2025, 12:20 PM
C4 Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 126.59M | 29.75M | 76.12M | 181.73M | 90.55M | 36.31M |
| Short-Term Investments | 127.09M | 246.4M | 233.16M | 189.96M | n/a | n/a |
| Long-Term Investments | 28.01M | 60.96M | 142.2M | 2.58M | 2.58M | 2.58M |
| Other Long-Term Assets | 6.17M | 4.8M | 3.82M | n/a | n/a | n/a |
| Receivables | 11.8M | 1.47M | 5.72M | 4.48M | 4.62M | 86.44M |
| Inventory | n/a | -60.96M | n/a | n/a | 1.00 | 1.00 |
| Other Current Assets | 5.71M | 9.93M | 21.39M | 9.67M | 3.19M | 781K |
| Total Current Assets | 271.19M | 287.56M | 325.69M | 381.01M | 96.77M | 123.53M |
| Property-Plant & Equipment | 71.09M | 77.52M | 35.05M | 16.55M | 18.92M | 20.38M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 105.26M | 143.28M | 181.08M | 19.13M | 21.49M | 22.96M |
| Total Assets | 376.45M | 430.84M | 506.76M | 400.14M | 118.26M | 146.49M |
| Account Payables | 1.45M | 1.17M | 4.51M | 5.68M | 5.38M | 1.15M |
| Deferred Revenue | 15.47M | 33.51M | 31.8M | 27.6M | 20.7M | 19.11M |
| Short-Term Debt | 5.22M | 11.69M | 2.67M | 2.08M | 880K | 734K |
| Other Current Liabilities | 20.63M | 15.07M | 12.27M | 8.48M | 27.38M | 2.95M |
| Total Current Liabilities | 42.77M | 44.55M | 51.25M | 43.85M | 33.64M | 23.95M |
| Long-Term Debt | 65.76M | 80.17M | 72.32M | 33.7M | 12.87M | 13.75M |
| Other Long-Term Liabilities | n/a | n/a | -30.78M | -11.83M | 111M | 111M |
| Total Long-Term Liabilities | 87.57M | 97.06M | 65.91M | 75.5M | 196.58M | 202.29M |
| Total Liabilities | 130.34M | 141.61M | 117.16M | 119.35M | 230.22M | 226.24M |
| Total Debt | 70.98M | 87.15M | 42.88M | 22.92M | 13.75M | 14.48M |
| Common Stock | 6K | 5K | 5K | 4K | 1K | 1K |
| Retained Earnings | -528.38M | -395.89M | -267.71M | -183.82M | -117.49M | -83.39M |
| Comprehensive Income | -127K | -4.14M | -775K | 13K | -1K | -2.5M |
| Shareholders Equity | 246.11M | 289.23M | 389.61M | 280.79M | -111.96M | -79.75M |
| Total Investments | 155.1M | 307.36M | 375.36M | 189.96M | 2.58M | 2.58M |